• Wed, December 15, 2021

Michael Ulz Maintained (CABA) at Buy with Decreased Target to $15 on, Dec 15th, 2021

Michael Ulz of Morgan Stanley, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $20 to $15 on, Dec 15th, 2021.

Michael has made no other calls on CABA in the last 4 months.



There is 1 other peer that has a rating on CABA. Out of the 1 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $17 on, Wednesday, December 8th, 2021

Like: 👍